HELLER ALAN L 4
4 · Neos Therapeutics, Inc. · Filed Jul 3, 2018
Insider Transaction Report
Form 4
HELLER ALAN L
Director
Transactions
- Award
Stock Option (Right to Buy)
2018-07-02+22,756→ 22,756 totalExercise: $6.05Exp: 2028-07-02→ Common Stock (22,756 underlying)
Footnotes (1)
- [F1]This stock option vests in equal quarterly installments over a one-year period which began on June 20, 2018.